Çмú´ëȸ VOD

´ëÇÑ´ëÀåÇ×¹®ÇÐȸ Á¦58Â÷ Çмú´ëȸ

Korean Society of Coloproctology 58th Annual Meeting
ÀÏ ½Ã: 2025³â 4¿ù 4ÀÏ~ 4¿ù 6ÀÏ, Àå ¼Ò: ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ

2025³â 4¿ù 4ÀÏ(±Ý)

[Abstract] Basic & Translational Research 1

08:30-08:40 Optimization of chitosan/hyaluronic acid-based hybrid patchs for anti-adhesive and prevention of anastomosis leakage °­¼öÁø °æºÏ´ëÇб³º´¿ø
08:40-08:50 Anticancer effect of PLK1 degrading PROTAC in colorectal cancer °­µ¿Çö ¼øÃµÇâ´ëÇб³ õ¾Èº´¿ø
08:50-09:00 Rearrangement of actomyosin cytoskeleton modulated with 3D-spheroids via RhoA/ROCK in internal anal sphincter-targeting model; preliminary results ¼ÕÀÏÅ ÇѸ²´ëÇб³ ¼º½Éº´¿ø
09:00-09:10 Impact of contrast phases on area and radiodensity measurements of skeletal muscle and adipose tissue °­Á¤Çö ¿¬¼¼ÀÇ´ë °­³²¼¼ºê¶õ½ºº´¿ø
09:10-09:20 Appendicitis-targeted generative enhanced image synthesis and three-dimensional deep learning-based diagnosis in non-contrast CT ±è¹Î¼º ÇѸ²´ëÇб³ ¼º½Éº´¿ø
09:20-09:30 Metagenomic profiling of the gut microbiome for predicting complete response to total neoadjuvant treatment in rectal cancer ÇãÁö¿ø Ãæ³²´ëÇб³ »ý¸íÁ¤º¸À¶ÇÕÇаú

[Abstract] IBD & Benign 1

08:30-08:40 Spatial transcriptomic analysis for genetic profiling of colitis-associated colorectal cancer in ulcerative colitis ¹ÚÀºÁ¤ ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø
08:40-08:50 Comparing surgical outcomes between Crohn’s disease and Gastrointestinal Behcet’s disease: a single-center retrospective cohort study ½Åµ¿Çö ¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø
08:50-09:00 Impact of aged care facility residence on 30-day mortality after emergency abdominal surgery for acute abdomen in the elderly ±èÁÖ¿¬ ±¹¹Î°Ç°­º¸Çè°ø´Ü Àϻ꺴¿ø
09:00-09:10 Analysis of extraintestinal manifestations in Korean patients with inflammatory bowel disease; A nationwide population-based study ¹Ú¼º½Ç ÇѾç´ëÇб³º´¿ø
09:10-09:20 ¿°Áõ¼º ÀåÁúȯÀÇ Ä¡·á °æÇâ º¯È­: ´ÜÀϱâ°ü ÈÄÇâÀû ºÐ¼® ¹è¿¹ÁØ °í·ÁÀÇ´ë
09:20-09:30 Comparison of hernia surgery outcomes in patients with and without prior prostatetectomy or cystectomy: A propensity score-matched analysis À¯È¿¼± °í·Á´ëÇб³ ¾È¾Ïº´¿ø

[Abstract] Neoplasia 1

08:30-08:40 Long-term outcomes according to the management of responsive lateral nodes after CCRT followed by rectal cancer surgery (RESPONDER): A multicenter retrospective cohort study using IPTW ¿ÀÈï±Ç ºÐ´ç¼­¿ï´ëÇб³º´¿ø
08:40-08:50 Albumin-myosteatosis gauge, a novel predictor of postoperative complication in colorectal cancer surgery with nomogram Á¶ÇýÁ¤ ¿¬¼¼´ëÇб³ Àǰú´ëÇÐ °­³²¼¼ºê¶õ½ºº´¿ø
08:50-09:00 Serial ctDNA analysis in stage IV colorectal cancer ¹®Áö¿¬ °¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø
09:00-09:10 Size matters: Establishing a cut-off for rectal neuroendocrine neoplasm to predict recurrence and standardize surveillance guidelines ±è¼¼Á¤ ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ
09:10-09:20 Comparative analysis of clinical characteristics between recurrence and non-recurrence patients after 5 years in colorectal cancer ¹ÚÁ¦¼º ¼­¿ï´ëÇб³º´¿ø
09:20-09:30 Neoadjuvant chemotherapy with four cycles of FOLFOX for locally advanced colon cancer: A multicenter prospective randomized controlled trial ¹Ú¼ö¿¬ °æºÏ´ëÇб³ Àǰú´ëÇÐ

[Next Generation] Painful Memories & Mistakes to Become a Great Surgeon

10:00-10:20 UFO (Unidentified foreign object) ±èâ¿ì ¾ÆÁÖÀÇ´ë       
10:20-10:40 Panic situations in operating room À¯½Â¹ü ¼­¿ïÀÇ´ë
10:40-11:00 Sleepless in anastomosis ¹ÚÁؼ® °æºÏÀÇ´ë
11:00-11:20 The struggles and growth that come with every step °èºÀÇö °¡Å縯ÀÇ´ë

[Hernia] Optimal Treatment for Difficult Situations

10:00-10:20 Recurred inguinal hernia ÀÌö½Â ÇѼֺ´¿ø
10:20-10:40 Incarcerated or strangulated inguinal hernia ±èÁöÈÆ °¡Å縯ÀÇ´ë
10:40-11:00 Obturator/Femoral hernia ±èÁ¾Å ÁøÁÖÁ¦ÀϺ´¿ø
11:00-11:20 Traumatic hernia ±è¿µ¹Î °¡ÃµÀÇ´ë

[Chemotherapy] Let's Dive into Chemotherapy to Be a Master of Oncology

10:00-10:15 Real practice and essentials for outpatient and inpatient chemotherapy ¼º³«¼Û °Ç¾çÀÇ´ë
10:15-10:30 All about chemotherapy induced adverse effect and its management to complete chemotherapy ±èÁ¾¿Ï ÇѸ²ÀÇ´ë
10:30-10:45 Evidence for adjuvant chemotherapy in rectal cancer after neoadjuvant chemotherapy °­¼ºÀÏ ¿µ³²ÀÇ´ë
10:45-11:00 Current evidence and role of ct-DNA for chemotherapy in colorectal cancer °­µ¿Çö ¼øÃµÇâÀÇ´ë
11:00-11:15 Optimal therapeutic strategies for systemic chemotherapy in metastatic colorectal cancer À̰æÇÏ Ãæ³²ÀÇ´ë

Luncheon Symposium (Sponsored by ONO Pharma)

11:30-12:00 A new standard treatment (BRAFTOVI¢ç) for BRAF V600E mutant mCRC ¹è±â¹ü ÀÎÁ¦ÀÇ´ë

[Áø·á±Ç°í¾ÈÀ§¿øÈ¸] Rectal Cancer Guideline v2.0: What's New

13:00-13:20 The role of radiotherapy in the treatment of upper rectal cancer À̱æ¿ë °¡Å縯ÀÇ´ë
13:20-13:40 Immunotherapy as a neoadjuvant treatment for locally advanced rectal cancer ±èÁø¿ø ¼­¿ïÀÇ´ë Á¾¾ç³»°ú
13:40-14:00 Is it okay to watch-and-wait? Áö¿õ¹è °í·ÁÀÇ´ë
14:00-14:20 Reviewing the oncologic outcomes of Transanal TME ³ë°æÅ ÀÌÈ­ÀÇ´ë

[Benign Colorectal Disease] All about Constipation & Ischemic Colitis

13:00-13:20 Pseuobstruction and slow transit constipation: causes and diagnosis/medical treatment ±èÂù¿í ¿ï»êÀÇ´ë
13:20-13:40 Pseuobstruction and slow transit constipation: surgical options and the best timing ÇÏ±â¿ø ÀüºÏÀÇ´ë
13:40-14:00 Management of ischemic colitis: medical treatment and long-term outcomes ¹®Èñ¼® Ãæ³²ÀÇ´ë ¼ÒÈ­±â³»°ú
14:00-14:20 Surgical management for ischemic colitis: various options (indication, anastomosis) ¾ç¼º¼ö ¿ï»êÀÇ´ë

[ÀÇ·áÁúÇâ»ó µ¥ÀÌÅÍÀ§¿øÈ¸] K-QIPS in Colorectal Surgery: Reflecting on the Past, Advancing Toward the Future

13:00-13:20 K-QIPS CRS: Review the past 3 years and plan the next 3 years ¹ÚÀ±¿µ °æÈñÀÇ´ë
13:20-13:40 Reviewing surgical risk calculation tools from global surgical quality improvement projects and planning a suitable approach for us ¼Û½ÂÈ£ °æºÏÀÇ´ë
13:40-14:00 What are research outcomes of K-QIPS CRS? Á¤Áø¿Á °í·ÁÀÇ´ë
14:00-14:20 Data Integrity: The current data audit status and suggestion for improvement À±¼ø¼® °í·ÁÀÇ´ë

Break (Video 1 - Surgeon's Square)

14:30-14:40 Optimal strategies to minimize the risk of anastomotic leakage: Prerequisites for safe anastomosis ±èÇýÁø °æºÏ´ëÇб³ Àǰú´ëÇÐ
14:40-14:50 Comparison of three different incision site approaches for Single-Port (SP) DaVinci¢ç right hemicolectomy Á¶ÇýÁ¤ ¿¬¼¼´ëÇб³ Àǰú´ëÇÐ °­³²¼¼ºê¶õ½ºº´¿ø
14:50-15:00 Advantages of Da Vinci SP robotic surgery for adhesiolysis and total mesorectal excision in obese rectal cancer patient ±èÈ£½Â ÀÌÈ­ÀÇ´ë

[¿¬±¸À§¿øÈ¸] ´Ù±â°ü ¿¬±¸ & Á¤Ã¥ ¿¬±¸ °ø¸ð

15:00-15:20 ´Ù±â°ü µ¥ÀÌÅ͸¦ ÅëÇÑ Á÷Àå ½Å°æ³»ºÐºñ Á¾¾çÀÇ Ä¡·á¹æ¹ý¿¡ µû¸¥ ¿¹ÈÄ ºÐ¼® ¹Ú¼º½Ç ÇѾçÀÇ´ë
15:20-15:40 Àü¹æÀýÁ¦¼ú ȤÀº ÀúÀ§Àü¹æÀýÁ¦¼ú ÈÄ º¹¸·¿Ü ÅͳθµÀ» ÅëÇÑ ¹è¾×°ü °íÁ¤¹ýÀÇ È¿¿ë¼º°ú ¾ÈÀü¼º¿¡ ´ëÇÑ ´Ù±â°ü ¹«ÀÛÀ§ ºñ±³ ¿¬±¸ °­¼ºÀÏ ¿µ³²ÀÇ´ë
15:40-16:00 °¨½Ã&´ë±â (Watch & Wait, W&W) Àü·« µ¥ÀÌÅͺ£À̽º ±¸Ãà »ç¾÷ ¹ÚÀ±¿µ °æÈñÀÇ´ë
16:00-16:20 º´¸®ÇÐÀû ÀúÀ§Ç豺 Á÷Àå¾ÏȯÀÚ¿¡¼­ º¸Á¶Ç×¾ÏÈ­Çпä¹ýÀÇ Çʿ伺¿©ºÎ ¹×
À§ÇèÀÎÀÚ ºÐ¼®: ´Ù±â°ü, ÈÄÇâÀû ¿¬±¸
±èÀÎ°æ °¡Å縯ÀÇ´ë

[Future Medicine] Cancer Biology

15:00-15:20 Colon cancer organoid model for therapeutic application ¹Ú¼Ò¿¬ ÀÌÈ­¿©´ë ¾àÇдëÇÐ
15:20-15:40 Control of microenvironment for colon cancer treatment Á¶¿ë¹ü ¼º±Õ°üÀÇ´ë
15:40-16:00 Organs on a chips: design and engineering ¾È¼ÛÀÌ Ä«À̽ºÆ® ±â°è°øÇаú
16:00-16:20 Patient-derived xenograft models for breast cancer research ¹®Çü°ï ¼­¿ïÀÇ´ë À¯¹æ³»ºÐºñ¿Ü°ú

[ÆíÁýÀ§¿øÈ¸] How to Prepare a Good Manuscript

15:00-15:20 How to initiate paper writing °­»óÈñ °í·ÁÀÇ´ë
15:20-15:40 How to summarize as attractive table and figure ¹ÚÀºÁ¤ ¿ï»êÀÇ´ë
15:40-16:10 Tips for making figures, graphs, and graphical/video abstracts À嵿¼ö ¿¬¼¼ÀÇ´ë, ÀÎÆ÷±×·¡ÇÇ´ëÇ¥
16:10-16:30 How to pass the review process easily À̼ö¿µ Àü³²ÀÇ´ë

[Abstract] Basic & Translational Research 2

17:00-17:10 Optimal indocyanine green dosage for repetitive angiography for laparoscopic colorectal surgery ¼Õ°æ¸ð ¾ç»êºÎ»ê´ëÇб³º´¿ø
17:10-17:20 Role of tumor microenvironment in the development of cancer cachexia ±èÈ£½Â ÀÌÈ­ÀÇ´ë
17:20-17:30 Biomarkers for predicting therapeutic response to preoperative chemoradiotherapy in rectal cancer ÀÌÃæ¿± ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø
17:30-17:40 Mechanistic insights into radiation resistance in colorectal cancer: Gene exploration study À̼öÇö ¼øÃµÇâÀÇ´ë õ¾Èº´¿ø
17:40-17:50 Identification of arginine (di)methylated human leukocyte antigen class I peptides in colon cancer tissues from patients ÀÓ¿ëö ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ
17:50-18:00 Early postoperative fever - when is it a reason to delay discharge after colorectal cancer surgery? ¹ÚÀçÇö ¼­¿ï´ëÇб³º´¿ø

[Abstract] Neoplasia 2

17:00-17:10 Two-week course versus conventionally fractionated preoperative chemoradiotherapy in locally advanced rectal cancer (TwoArc trial): A phase III multicenter randomized clinical trial °èºÀÇö °¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø
17:10-17:20 Implications of CME as a predictive factor for peritoneal recurrence of cT3-4 right-sided colon cancer: A multicenter retrospective study ¼Û½ÂÈ£ Ä¥°î°æºÏ´ëº´¿ø
17:20-17:30 The clinical utility of blood-based multi-locus circulating tumor DNA methylation assay for colorectal cancer diagnosis: Prospective case-control study, interim results ÀÌÇÏ¿µ °­µ¿°æÈñ´ëº´¿ø
17:30-17:40 Pilot study of implementing prehabilitation program to rectal cancer patients undergoing preoperative concurrent chemoradiation therapy À¯´Ï³ª °¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø
17:40-17:50 Nomogram for prediction of lymph node metastasis after neoadjuvant chemoradiotherapy in ypT0-2 rectal cancer ¹ÚÇü¹Î È­¼øÀü³²´ëÇб³º´¿ø
17:50-18:00 Endoscopic treatment for rectal neuroendocrine tumors: Comparison among EMR, EMR-P, and ESD ÀÌÀºÁ¤ À寰À§Æ°º´¿ø

[Abstract] Neoplasia 3

17:00-17:10 Impact of inferior mesenteric artery ligation level on anastomotic leakage in low anterior resection: A multicenter RCT ±èâÇö Àü³²´ëÇб³ Àǰú´ëÇÐ
17:10-17:20 Prognostic factors and oncologic benefits of adjuvant chemotherapy in pT3N0 rectal cancer after upfront surgery °­°æ¹Î ºÐ´ç¼­¿ï´ëÇб³º´¿ø
17:20-17:30 Watch-and-wait policy to defer defunctioning stoma after low anterior resection: Preliminary results from the safe anastomosis project ±èÇýÁø °æºÏ´ëÇб³ Àǰú´ëÇÐ
17:30-17:40 Comparison of long-term oncological outcomes between robotic and laparoscopic total mesorectal excision for rectal cancer: A propensity score matching analysis ¹è¼º¿í °è¸íÀǴ뵿»êÀÇ·á¿ø
17:40-17:50 Optimal age cut-off for oxaliplatin-based versus non-oxaliplatin adjuvant chemotherapy in stage II/III colorectal cancer: A Korean population-based study ºÀÁØ¿ì °í·Á´ëÇб³ ±¸·Îº´¿ø
17:50-18:00 Risk factors for LN metastasis in T1 colorectal cancer : A retrospective, single-center, comparative study ¹ÚÁøÇü °¡Å縯ÀÇ´ë ÀºÆò¼º¸ðº´¿ø